ESSEX INVESTMENT MANAGEMENT CO LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 201772 BOSTON, MA

Position in TVTX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$7,604,927

+$2,800,672 QoQ

Shares Held

133,866

-17.2% QoQ

Ownership

0.142%

of shares outstanding

% of Portfolio

1.02%

of 13F equity value

Holder Rank

#87

of 315 holders

Holding Since

Dec 2021

9 quarters on record

Voting authority Sole 51% Shared 0% None 49%

Healthcare · as of Jun 30, 2026

ESSEX INVESTMENT MANAGEMENT CO LLC holds $67,663,995 across 13 Biotechnology names. TVTX ranks #3 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	43,567	$13,771,093
2	MIRM	Mirum Pharmaceuticals, Inc.	105,669	$12,370,669
3	TVTX	Travere Therapeutics, Inc. This page	133,866	$7,604,927
4	JAZZ	Jazz Pharmaceuticals plc	21,665	$5,220,615
5	OCUL	Ocular Therapeutix, Inc	482,154	$4,734,752
6	INSM	INSMED Inc	42,991	$4,583,700
7	PGEN	Precigen, Inc.	706,294	$4,025,875
8	AXSM	Axsome Therapeutics, Inc.	16,244	$3,976,043

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,604,927	133,866	-17.2%	Shares	Sole	2026-08-06
2026-03-31	$4,804,255	161,705	+1.9%	Shares	Sole	2026-05-11
2025-12-31	$6,064,270	158,709	-2.0%	Shares	Sole	2026-02-13
2025-09-30	$3,871,513	161,988	-36.4%	Shares	Sole	2025-11-06
2025-03-31	$4,563,614	254,666	+342.1%	Shares	Sole	2025-05-07
2022-09-30	$1,419,387	57,605	+7.9%	Shares	Sole	2022-11-14
2022-06-30	$1,293,470	53,383	-1.4%	Shares	Sole	2022-08-12
2022-03-31	$1,394,569	54,116	+7.6%	Shares	Sole	2022-05-09
2021-12-31	$1,561,343	50,301	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.